ArticleFrontiers in oncology2026

A pathological classification for predicting recurrence and guiding adjuvant therapy in esophageal squamous cell carcinoma following neoadjuvant immunochemotherapy: a two-center cohort study.

Jiaming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.